Literature DB >> 29405435

Immediate post-operative broncho-alveolar lavage IL-6 and IL-8 are associated with early outcomes after lung transplantation.

Stijn E Verleden1, An Martens2, Sofie Ordies2, Arne P Neyrinck2, Dirk E Van Raemdonck1, Geert M Verleden1, Bart M Vanaudenaerde1, Robin Vos1.   

Abstract

INTRODUCTION: Previous studies demonstrated that increased cytokine and chemokine levels, either shortly before or after lung transplantation, were associated with post-transplant outcome. However, small patient cohorts were mostly used, focusing on 1 molecule and 1 outcome. In a large single-center cohort, we investigated the predictive value of immediate post-operative broncho-alveolar lavage (BAL) expression of IL-6 and IL-8 on multiple key outcomes, including PGD, CLAD, graft survival, as well as several secondary outcomes.
MATERIAL AND METHODS: All patients undergoing a first lung transplant in whom routine bronchoscopy with BAL was performed during the first 48 hours post-transplantation were included. IL-6 and IL-8 protein levels were measured in BAL via ELISA.
RESULTS: A total of 336 patients were included. High IL-6 levels measured within 24 hours of transplantation were associated with longer time on ICU and time to hospital discharge; and increased prevalence of PGD grade 3. Increased IL-8 levels, measured within 24 hours, were associated with PGD3, more ECMO use, higher donor paO2 , younger donor age, but not with other short-or long-term outcome. IL-6 and IL-8 measured between 24 and 48 hours of transplantation were not associated with any outcome parameters.
CONCLUSION: Recipient BAL IL-6 and IL-8 within 24 hours post-transplant were associated with an increased incidence of PGD3.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-6; IL-8; lung transplantation; outcome; primary graft dysfunction

Mesh:

Substances:

Year:  2018        PMID: 29405435     DOI: 10.1111/ctr.13219

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  10 in total

1.  Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion.

Authors:  Roumen Parapanov; Xingyu Wang; Yabo Wang; Anne Debonneville; Jérôme Lugrin; Lucas Liaudet; Thorsten Krueger
Journal:  Transplant Direct       Date:  2022-06-10

Review 2.  Pathobiology of frailty in lung disease.

Authors:  Brittany Koons; John R Greenland; Joshua M Diamond; Jonathan P Singer
Journal:  Transl Res       Date:  2020-05-03       Impact factor: 7.012

3.  IL-6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome.

Authors:  Peter Riddell; Sajad Moshkelgosha; Liran Levy; Nina Chang; Prodipto Pal; Kieran Halloran; Phil Halloran; Michael Parkes; Lianne G Singer; Shaf Keshavjee; Tereza Martinu; Stephen C Juvet
Journal:  Clin Transl Immunology       Date:  2021-01-28

Review 4.  The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Edward J Filippone
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

Review 5.  Novel approaches for long-term lung transplant survival.

Authors:  Cynthia L Miller; Jane M O; James S Allan; Joren C Madsen
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

6.  Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients.

Authors:  Emmanuel Schneck; Ingolf Askevold; Ramona Rath; Andreas Hecker; Martin Reichert; Stefan Guth; Christian Koch; Michael Sander; Werner Seeger; Konstantin Mayer; Winfried Padberg; Natascha Sommer; Stefan Kuhnert; Matthias Hecker
Journal:  J Clin Med       Date:  2022-07-16       Impact factor: 4.964

Review 7.  Effector immune cells in chronic lung allograft dysfunction: A systematic review.

Authors:  Saskia Bos; Andrew J Filby; Robin Vos; Andrew J Fisher
Journal:  Immunology       Date:  2022-03-01       Impact factor: 7.215

8.  Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies.

Authors:  Meng-Xi Xiu; Zu-Ting Liu; Jian Tang
Journal:  Int Immunopharmacol       Date:  2020-08-10       Impact factor: 4.932

Review 9.  IL-6 Directed Therapy in Transplantation.

Authors:  Cynthia L Miller; Joren C Madsen
Journal:  Curr Transplant Rep       Date:  2021-06-03

Review 10.  The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.

Authors:  Jasper Iske; Christopher A Hinze; Jawad Salman; Axel Haverich; Stefan G Tullius; Fabio Ius
Journal:  Am J Transplant       Date:  2021-08-24       Impact factor: 8.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.